Latest Breaking News On - University of miami health system miguel saps - Page 1 : vimarsana.com

The new data was published in The Lancet Gastroenterology & Hepatology and highlighted additional efficacy endpoints from the study used to support linaclotide’s FDA approval in 2023.

Georgee batchelorMichael shetzlineDrug administrationUniversity of miamiIronwood pharmaceuticals announcesIronwood pharmaceuticalsUniversity of miami health system miguel sapsMiami health systemMiguel sapsLancet gastroenterologyEndowed chairBristol stool form scaleIronwood announces publicationNew linaclotide phaseAdolescents agedNew indication